C

Concert Pharmaceuticals Inc
F:73C

Watchlist Manager
Concert Pharmaceuticals Inc
F:73C
Watchlist
Price: 7.818 EUR Market Closed
Market Cap: 374.8m EUR

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of 73C.

The Intrinsic Value is calculated as the average of DCF and Relative values:

73C Intrinsic Value
Not Available
C
Base Case Scenario
Compare 73C to

Fundamental Analysis

Concert Pharmaceuticals Inc
F:73C
US
Biotechnology
Market Cap
374.8m EUR
IPO
Feb 13, 2014
US
Biotechnology
Market Cap
374.8m EUR
IPO
Feb 13, 2014
Price
€
$
Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about 73C?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Concert Pharmaceuticals Inc

Current Assets 157.2m
Cash & Short-Term Investments 149.5m
Receivables 1.6m
Other Current Assets 6m
Non-Current Assets 13.9m
PP&E 12.8m
Other Non-Current Assets 1.2m
Current Liabilities 17.4m
Accounts Payable 2.7m
Accrued Liabilities 4.7m
Other Current Liabilities 9.9m
Non-Current Liabilities 20.5m
Other Non-Current Liabilities 20.5m
Efficiency

Free Cash Flow Analysis
Concert Pharmaceuticals Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Concert Pharmaceuticals Inc

Revenue
42k USD
Operating Expenses
-160.3m USD
Operating Income
-160.3m USD
Other Expenses
-3.7m USD
Net Income
-164m USD
Fundamental Scores

73C Profitability Score
Profitability Due Diligence

Concert Pharmaceuticals Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

18/100
Profitability
Score

Concert Pharmaceuticals Inc's profitability score is 18/100. The higher the profitability score, the more profitable the company is.

73C Solvency Score
Solvency Due Diligence

Concert Pharmaceuticals Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Long-Term Solvency
Low D/E
Low Altman Z-Score
61/100
Solvency
Score

Concert Pharmaceuticals Inc's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

73C Price Targets Summary
Concert Pharmaceuticals Inc

There are no price targets for 73C.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for 73C is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y